The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Continuous monitoring via implantable loop recorder ...

Experts note that implantable loop recorders are valuable for detecting infrequent arrhythmias and guiding anticoagulation decisions post-cryptogenic stroke or atrial fibrillation ablation, but due to ...

Please provide your email address to receive an email when new articles are posted on . Continuous implantable loop recorder monitoring resulted in a threefold increase in atrial fibrillation ...

Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common cardiac arrhythmia, today announces enrolment of the first patients ...

Atrial fibrillation was diagnosed in 477 of 1,501 (31.8%) participants in the monitoring group and 550 of 4,503 (12.2%) participants in the control group (HR 3.17, 95% CI 2.81-3.59, P<0.001), reported ...

Patients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall, but a subset of patients whose heart attack was ...

Barcelona, Spain, 1 September 2009: The REVISE Study (Reveal in the Investigation of Syncope and Epilepsy) found that 1 in 8 adult patients in the United Kingdom, previously thought to be suffering ...

Patients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall, but a subset of patients whose heart attack was ...

Experts discuss how choosing the right cardiac rhythm monitor involves balancing symptom frequency, patient risk, and device capabilities to ensure efficient, cost-effective, and patient-centered ...

Given today's short hospital stays after transcatheter aortic valve replacement (TAVR), there may be a role for selective long-term monitoring to flag delayed conduction abnormalities, studies showed.

Two new randomized trials have added to the evidence that rates of atrial fibrillation (AF) detection are increased through the use of long-term monitoring with implantable devices. The studies have ...